Pain and Inflammation Research

Although separate conditions, pain and inflammation are nearly always associated with each other. Pain is defined by the International Association for the Study of Pain (IASP) as 'an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage'. Inflammation is the tissue's immunologic response to injury, characterized by mobilization of white blood cells and antibodies, swelling, and fluid accumulation.

Pain and Inflammation Research Products Areas

Products for Pain and Inflammation Research - Page 42

  1. Cat.No. Product Name Information/Activity
  2. BCC3942 Cilengitide Cilengitide, a cyclic RGD-containing peptide, is a potent and selective integrin inhibitor for αvβ3 and αvβ5 receptor, with IC50s of 4 and 79 nM, respectively. Cilengitide chemical structure
  3. BCC5988 Echistatin, α1 isoform 154303-05-6 Echistatin, α1 isoform chemical structure
  4. BCC6998 GR 144053 trihydrochloride 1215333-48-4 GR 144053 trihydrochloride chemical structure
  5. BCC5938 KF 38789 257292-29-8 KF 38789 chemical structure
  6. BCC6229 LDV FITC 1207610-07-8 LDV FITC chemical structure
  7. BCC6332 Leukadherin 1 Leukadherin-1 is a specific agonist of complement receptor 3 (CR3) and the leukocyte surface αMβ2 integrin CD11b/CD18. Leukadherin 1 chemical structure
  8. BCC3943 MNS MNS is a potent and selective inhibitor of Src and Syk tyrosine kinases. MNS chemical structure
  9. BCC7458 OGT 2115 OGT 2115 is a potent, cell-permeable and orally active heparanase inhibitor with an IC50 of 0.4 μM. OGT 2115 has anti-angiogenic properties (IC50 of 1 μM). OGT 2115 also inhibits heparan sulfate degradation activity. OGT 2115 chemical structure
  10. BCC6275 P11 848644-86-0 P11 chemical structure
  11. BCC6105 PM 102 1234564-95-4 PM 102 chemical structure

Items 411 to 420 of 1162 total